GLP-1 Meds: Things To Consider Before Taking The Latest Miracle Weight Loss Drug

GLP-1 medications have gained significant popularity in the health and fitness world in recent years. Whether at diabetes clinics, weight-loss centers, or in national news, you’ve probably heard names like Ozempic, Wegovy, Mounjaro, Saxenda, and Trulicity. These drugs, often called “GLP-1s,” are now some of the most talked-about medications in modern medicine.

But what exactly are these medications and how do they work? And why is there so much debate about their use and safety? In this guide, we’ll explain how GLP-1s affect the body to achieve weight loss, why they are prescribed, potential side effects, benefits and risks, and what to consider whether you are thinking about using them or already do.

What Are GLP-1 Medications? 

“GLP-1” stands for glucagon-like peptide-1. This is a hormone your body naturally produces in the gut in response to eating. One of its functions is to signal the pancreas to release insulin while also decreasing glucagon, a hormone that raises blood sugar. It also affects stomach emptying and appetite signals in the brain, which makes you feel fuller longer. GLP-1 medications are synthetic versions of this hormone. They bind to the same receptors in the body and amplify the natural effects of GLP-1, but in a controlled and often stronger way than what our bodies typically produce. Examples of GLP-1 receptor agonists include:

• Semaglutide – found in brand names like Ozempic (typically for diabetes) and Wegovy (for weight management)

• Liraglutide – used in Victoza (diabetes) and Saxenda (weight loss)

• Dulaglutide – in Trulicity

Other newer agents, such as tirzepatide (found in Mounjaro/Zepbound), target GLP-1 and, in some cases, additional pathways like GIP (Glucose-dependent Insulinotropic Polypeptide). There are also experimental compounds currently undergoing clinical trials, like Retatrutide which targets three receptor pathways.GLP-1 medications can be given as weekly injections, and in some cases, now even as daily pills (e.g., a new oral Wegovy formulation), which expands options for patients and providers.

Mechanism of Action: How GLP-1 Medications Work

Understanding the function of GLP-1 medications helps to explain both their benefits and their side effects. At a biological level, GLP-1 receptor agonists act in several key ways:

• Stimulate Insulin Release: When blood sugar levels rise after eating, GLP-1 medications stimulate the secretion of insulin from pancreatic cells. This helps lower blood sugar in people with type 2 diabetes.

• Reduce Glucagon Secretion: Glucagon triggers the liver to release stored glucose. GLP-1 medications decrease glucagon release, helping prevent excess glucose in the bloodstream.

• Slow Gastric Emptying: GLP-1s slow the speed at which the stomach empties food into the small intestine. This prolongs feelings of fullness and can reduce appetite and overall calorie intake, a key reason they help with weight loss.

• Act on the Brain: GLP-1 receptor agonists influence appetite and hunger signals in the brain, which reduces cravings and makes it easier to eat less and resist high-calorie foods.

Taken together, these mechanisms make GLP-1 medications a powerful tool for improving blood sugar control and aiding weight loss, two closely linked health goals for many people.

Why Are GLP-1 Medications Prescribed?

GLP-1 medications were originally developed to manage type 2 diabetes. For people with type 2 diabetes, these medications help lower blood glucose levels and have been shown in studies to reduce the risk of cardiovascular complications.

However, their appetite-reducing effects and metabolic benefits led researchers to test higher doses specifically for weight loss, which is why drugs like Wegovy and Saxenda are now approved for treatment of obesity or weight management in addition to diabetes. Common reasons a clinician might prescribe a GLP-1 medication include:

• Managing type 2 diabetes when diet, exercise, and first-line medications like metformin are not enough.

• Chronic weight management for individuals with obesity (e.g., BMI ≥ 30 kg/m²) or overweight with related conditions like hypertension or sleep apnea.

• Reducing cardiovascular risk, particularly in diabetics with heart disease.

• Sometimes off-label uses (under careful medical guidance), though these require close monitoring.

While not recommended for children or during pregnancy and breastfeeding due to limited safety data, new formulations and ongoing research continue to expand understanding of where these drugs may be useful.

Common Side Effects

Like any medication, GLP-1 drugs come with a range of side effects. Some are mild and transient; others are more serious but rare. Knowing what to expect can help patients communicate with their clinicians and manage their therapy effectively.

• Gastrointestinal Effects: The side effects most often reported involve the digestive system, including nausea and vomiting, diarrhea or constipation, abdominal discomfort, and bloating. These symptoms are most frequent when treatment begins or when doses are increased and often improve over time as the body adjusts.

• Appetite and Eating Changes: Because GLP-1 meds slow digestion and suppress hunger, many users report reduced appetite or changes in how food tastes or feels. This can be beneficial for weight loss, but it can create challenges with daily eating patterns.

• Rare but Serious Risks: While uncommon, there are serious medical considerations linked to GLP-1 use:

  - Pancreatitis: Inflammation of the pancreas has been reported; symptoms include

  severe abdominal pain, nausea, and vomiting. This side effect is considered rare but

  important to monitor.

- Gallbladder Issues: Rapid weight loss and altered digestion can contribute to the

formation of gallstones or gallbladder inflammation.

- Thyroid Concerns: Animal studies have shown thyroid C-cell tumors in rodents,

leading to caution in humans with certain risk histories (e.g., medullary thyroid

cancer). However, a significant risk in humans hasn’t been proven.

- Hypoglycemia: Low blood sugar levels can occur, especially when used with other

medications that lower glucose, such as insulin or sulfonylureas.

- Delayed Gastric Emptying Complications: In rare cases, delayed digestion can be

severe enough to cause stomach paralysis or intestinal obstruction (ileus).

Reports have also highlighted concerns such as thought changes or mood effects — though causal links are not definitively proven — and very rare eye-related issues that are still under investigation. Due to these possible side effects, healthcare providers carefully assess medical history before prescribing and monitor for red-flag symptoms throughout therapy.

Pros of Using GLP-1 Medications

Despite potential side effects, many people receive significant benefits from GLP-1 therapy. Here are some of the main advantages:

• Effective Blood Sugar Control: For people with type 2 diabetes, GLP-1 drugs lower A1C levels and help stabilize glucose, which can minimize dependency on other medications.

• Weight Loss and Appetite Control: GLP-1 receptor agonists can lead to meaningful weight loss for many users. Clinical trials have shown substantial reductions in body weight, especially with higher-dose formulations like Wegovy.

• Cardiovascular and Metabolic Benefits: Some GLP-1 medications have been shown to reduce cardiovascular events (heart attack and stroke) and may improve lipid profiles and blood pressure.

• Convenience of Dosing: Weekly injection schedules of GLP-1 medications, when compared with multiple daily medications, can simplify treatment routines for some patients.

• Potential Additional Health Effects: Emerging research suggests potential benefits in conditions like fatty liver disease and kidney protection in diabetes.
  

Additional Things to Consider

First and foremost, use of a GLP-1 should accompany a proper diet and exercise program. When a patient uses a GLP-1 without considering nutrition or exercise, they continue to eat a similar diet, albeit a smaller amount. Many Americans already do not eat enough protein, fiber, or micronutrients. If that is the case for a patient, and the food intake becomes smaller, nutritional gaps become larger. A lack of protein and resistance training could contribute to a potential loss of muscle mass. This means that while overall bodyweight has decreased, body composition remains the same or even worsens. This guide to GLP-1 medications provides you with information about risks, benefits, and reasons to consider integrating these medications into your lifestyle; however, this guide is for informational purposes only and is not intended to treat or diagnose any medical conditions. Always consult with your physician prior to beginning a new medication. We also suggest consulting with both a Certified Nutritionist and a Certified Personal Trainer for enhanced benefits and results, even after cessation of a GLP-1 medication. REFERENCES

1. American Diabetes Association. (2023). Pharmacologic approaches to glycemic treatment: Standards of care in diabetes—2023. Diabetes Care, 46(Suppl. 1), S140–S157. https://doi.org/10.2337/dc23-S009 

2. BMJ Publishing Group. (2012). Glucagon-like peptide-1 receptor agonists for type 2 diabetes mellitus: Systematic review and meta-analysis. BMJ, 344, d7771. https://www.bmj.com/content/344/bmj.d7771 

3. Endocrinology Advisor. (n.d.). GLP-1 receptor agonists. https://www.endocrinologyadvisor.com/ddi/glp-1-agonists/ 

4. Harvard Health Publishing. (2023). How does Ozempic work? Understanding GLP-1s for diabetes, weight loss, and beyond. Harvard Medical School. https://www.health.harvard.edu/staying-healthy/how-does-ozempic-work-understanding-glp-1s-for-diabetes-weight-loss-and-beyond 

5. Mayo Clinic. (2023). Diabetes drugs: GLP-1 agonists. https://www.mayoclinic.org/diseases-conditions/type-2-diabetes/expert-answers/byetta/faq-20057955 

6. ModMed. (2024). Pros and cons of GLP-1 use. https://www.modmedatx.com/blog-1-1/pros-and-cons-of-glp-1-use 

7. National Center for Biotechnology Information. (2023). Glucagon-like peptide-1 receptor agonists. In StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK551568/ 

8. Nature Medicine. (2024). Risk of gastrointestinal and metabolic adverse events associated with GLP-1 receptor agonists. Nature Medicine, 30, 123–131. https://www.nature.com/articles/s41591-024-03412-w 

9. SolvHealth. (n.d.). What is a GLP-1 receptor agonist? A complete overview. https://www.solvhealth.com/health/what-is-glp-1-receptor-agonist-a-complete-overview 

10. U.S. Food and Drug Administration. (2023). Drug safety communication: GLP-1 receptor agonists. https://www.fda.gov/drugs 

11. Virta Health. (2023). Wegovy vs. Ozempic: What’s the difference? https://www.virtahealth.com/glp-1-comparisons/wegovy-vs-ozempic